Compare TRVG & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRVG | MOBI |
|---|---|---|
| Founded | 2005 | N/A |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.4M | 383.0M |
| IPO Year | 2015 | 2026 |
| Metric | TRVG | MOBI |
|---|---|---|
| Price | $4.90 | $11.42 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.95 | N/A |
| AVG Volume (30 Days) | 86.7K | ★ 90.5K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.59 | N/A |
| Revenue Next Year | $8.42 | N/A |
| P/E Ratio | $16.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.59 | $10.34 |
| 52 Week High | $5.91 | $15.19 |
| Indicator | TRVG | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 40.96 | 45.44 |
| Support Level | $2.76 | $10.73 |
| Resistance Level | $5.77 | $12.68 |
| Average True Range (ATR) | 0.31 | 1.00 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 24.63 | 34.75 |
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.